UK 66838
Latest Information Update: 18 Apr 2000
Price :
$50 *
At a glance
- Originator Pfizer
- Class Cardiotonics
- Mechanism of Action Phosphoric diester hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 18 Apr 2000 Profile reviewed but no significant changes made
- 02 Jul 1996 No-Development-Reported for Heart failure in United Kingdom (Unknown route)